Calamos Advisors LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,044,343
-15.0%
18,354
-40.9%
0.01%
-16.7%
Q3 2022$1,228,000
-72.3%
31,051
-69.2%
0.01%
-68.4%
Q2 2022$4,432,000
+65.2%
100,724
+56.5%
0.02%
+26.7%
Q1 2021$2,683,000
-46.6%
64,359
-45.3%
0.02%
-48.3%
Q4 2020$5,028,000
+99.0%
117,716
+22.4%
0.03%
+81.2%
Q3 2020$2,527,000
+101.7%
96,171
+105.9%
0.02%
+77.8%
Q2 2020$1,253,00046,7030.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders